Decreased signs of inflammation and no erosive progression on ultrasonography at 6 and 12 months in patients with rheumatoid arthritis in adalimumab and methotrexate combination therapy.

Uffe Døhn, Marcin Szkudlarek, Michael Sejer Hansen, Merete Lund Hetland, Annette Hansen, Ole Rintek Madsen, Maria Hasselquist, Mikkel Østergaard

    OriginalsprogEngelsk
    TidsskriftAnnals of the Rheumatic Diseases
    Vol/bind69
    Udgave nummer3
    Sider (fra-til)457
    Antal sider1
    ISSN0003-4967
    StatusUdgivet - 2010

    Citationsformater